MONTREAL, Nov. 1 /CNW Telbec/ - A new study by scientists at the MUHC has
revealed that a low level of folate in our diet increases our risk of
developing colorectal cancer. Published in the scientific journal Cancer
Research today, the study not only illustrates a way to prevent the disease
but also provides further insight into the mechanisms of the disease, which
could lead to novel therapies. Using animal models, the MUHC study is the
first to demonstrate directly that diets low in folate cause colorectal
cancer, and follows on the heels of earlier research by the same team that
revealed how high folate diets can protect against heart disease.
"This research, which is consistent with previous epidemiological studies
in humans, demonstrates a clear link between low dietary folate and the
initiation of colorectal cancer in animal models," says Dr. Rima Rozen,
Scientific Director of the Montreal Children's Hospital, Deputy Scientific
Director of the MUHC, and lead investigator in the study. "None of the mice
fed a control diet developed tumours whereas 1 in 4 mice on the
folate-deficient diet developed at least one tumour."
Possible mechanisms of the disease were also investigated using molecular
biological techniques. "The study shows that a low level of dietary folate may
cause an increase in DNA damage, which plays a role in the development of
tumours," noted Dr. Rozen. The study also reveals that folate deficiency
causes genes which usually respond to DNA damage to behave abnormally, also
contributing to the development of tumours. The results suggest that a diet
containing sufficient folate may reduce the risk of developing colorectal
"It is estimated that 20,000 men and women will be diagnosed with
colorectal cancer this year, and an estimated 8,500 will die from the disease.
The result of this study highlights how simply adding a supplement to your
daily diet could have tremendous long-term benefits to the individual and the
health care system," said Dr. Philip Branton, Scientific Director of the CIHR
Institute of Cancer Research. "While these results are encouraging, much more
research will be needed before we will know for certain if folate has any
protective effect for colorectal cancer in men," added Dr. Branton.
The intake of an adequate amount of dietary folate has also been shown to
prevent a number of other diseases. "For example, birth defects such as Spina
Bifida, can result in offspring of mothers with inadequate folate in their
diet," says Dr. Rozen. In March of this year, the same team revealed how diets
with the recommended levels of folate can protect against heart disease (see:
http://www.muhc.ca/media/news/?ItemID=19284). "Obviously, this is not a reason
to consume excessive amounts of folate, but rather to ensure that the
recommended daily amount is taken through a healthy diet or a vitamin
supplement," noted Dr. Rozen. The benefits of a high folate diet have been
known for many years. Both the US and Canada have regulations requiring the
addition of folic acid (the synthetic form of folate) to breads, cereals,
flours, corn meals, pastas and rice to increase its intake in the general
Colorectal cancer affects approximately 5% of the population. The
majority of cases are sporadic and due mainly to environmental factors.
Hereditary forms can account for up to 15% of all colorectal cancers.
Funding for this study was provided by the Canadian Institutes of Health
The Research Institute of the McGill University Health Centre (RI MUHC)
is a world-renowned biomedical and health-care hospital research centre.
Located in Montreal, Quebec, the institute is the research arm of the MUHC, a
university health center affiliated with the Faculty of Medicine at McGill
University. The institute supports over 500 researchers, nearly 1000 graduate
and post-doctoral students and operates more than 300 laboratories devoted to
a broad spectrum of fundamental and clinical research. The Research Institute
operates at the forefront of knowledge, innovation and technology and is
inextricably linked to the clinical programs of the MUHC, ensuring that
patients benefit directly from the latest research-based knowledge. For
further details visit: www.muhc.ca/research.
The McGill University Health Centre (MUHC) is a comprehensive academic
health institution with an international reputation for excellence in clinical
programs, research and teaching. The MUHC is a merger of five teaching
hospitals affiliated with the Faculty of Medicine at McGill University--the
Montreal Children's, Montreal General, Royal Victoria, and Montreal
Neurological Hospitals, as well as the Montreal Chest Institute. Building on
the tradition of medical leadership of the founding hospitals, the goal of the
MUHC is to provide patient care based on the most advanced knowledge in the
health care field, and to contribute to the development of new knowledge.